The Changing Clinical Spectrum of Hypophysitis

Tommaso Tartaglione, Alfredo Pontecorvi, Sabrina Chiloiro, Ettore Domenico Capoluongo, Antonella Giampietro, Andrea Giustina

Research output: Contribution to journalArticle

10 Citations (Scopus)


Hypophysitis is a rare and potentially life-threatening disease, characterized by an elevated risk of complications, such as occurrence of acute central hypoadrenalism, persistent hypopituitarism, or extension of the inflammatory process to the neighboring neurological structures. In recent years, a large number of patients have been described as being affected by hypophysitis, due to the increased administration of immuno-chemotherapies. At the present time, the heterogeneous nature of hypophysitis diagnostic criteria and of the treatment protocols makes the management of affected patients difficult. We review the current data and evidence on primary and secondary hypophysitis, in order to suggest a diagnostic and therapeutic protocol that should be focused on a multidisciplinary approach, for reaching a prompt diagnosis and an appropriate and safe treatment.
Original languageEnglish
Pages (from-to)590-602
Number of pages13
JournalTrends in Endocrinology and Metabolism
Publication statusPublished - 2019


  • Hormone Replacement Therapy
  • Humans
  • Hypophysitis
  • Immunosuppressive Agents
  • Pituitary Gland
  • autoimmune
  • diabetes insipidus
  • hypopituitarism
  • immunotherapy
  • ipilimumab
  • pituitary

Fingerprint Dive into the research topics of 'The Changing Clinical Spectrum of Hypophysitis'. Together they form a unique fingerprint.

Cite this